Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

950 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 417
Recruiting: 234
Ph III recruiting: 22
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (168)

clinicaltrialsPublishedShowing 101–123 of 123 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04099277	A Study of LY3435151 in Participants With Solid Tumors	terminated	Phase 1	2	Eli Lilly and CompanyINDUSTRY	2	Aug 31, 2021	clinicaltrials
NCT03186937	A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer	terminated	Phase 2	6	University of Wisconsin, MadisonOTHER	1	Aug 18, 2021	clinicaltrials